HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tomokazu Ohishi Selected Research

Epithelial Cell Adhesion Molecule

1/2023Antitumor activities of a defucosylated anti‑EpCAM monoclonal antibody in colorectal carcinoma xenograft models.
11/2022A Defucosylated Anti-EpCAM Monoclonal Antibody (EpMab-37-mG2a-f) Exerts Antitumor Activity in Xenograft Model.
12/2020The anti-epithelial cell adhesion molecule (EpCAM) monoclonal antibody EpMab-16 exerts antitumor activity in a mouse model of colorectal adenocarcinoma.
12/2020Anti‑EpCAM monoclonal antibody exerts antitumor activity against oral squamous cell carcinomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tomokazu Ohishi Research Topics

Disease

61Neoplasms (Cancer)
02/2024 - 03/2002
9Pancreatic Neoplasms (Pancreatic Cancer)
12/2023 - 06/2020
8Stomach Neoplasms (Stomach Cancer)
02/2024 - 08/2019
8Neoplasm Metastasis (Metastasis)
01/2023 - 04/2018
8Squamous Cell Carcinoma of Head and Neck
02/2022 - 04/2018
7Breast Neoplasms (Breast Cancer)
02/2024 - 06/2020
7Colorectal Neoplasms (Colorectal Cancer)
01/2023 - 08/2017
6Obesity
07/2023 - 01/2016
6Colonic Neoplasms (Colon Cancer)
08/2021 - 03/2002
5Carcinogenesis
01/2023 - 03/2002
5Mouth Neoplasms (Oral Cancer)
12/2020 - 09/2018
4Glioblastoma (Glioblastoma Multiforme)
12/2023 - 08/2020
4Cardiovascular Diseases (Cardiovascular Disease)
07/2023 - 01/2016
4Lung Neoplasms (Lung Cancer)
02/2023 - 10/2020
3Inflammation (Inflammations)
07/2023 - 01/2016
3Osteosarcoma (Osteogenic Sarcoma)
02/2023 - 12/2021
3Infections
01/2022 - 07/2017
3Neurodegenerative Diseases (Neurodegenerative Disease)
01/2021 - 01/2016
3Melanoma (Melanoma, Malignant)
12/2020 - 03/2019
2Alzheimer Disease (Alzheimer's Disease)
07/2023 - 05/2018
2Urinary Bladder Neoplasms (Bladder Cancer)
01/2023 - 01/2017
2Renal Cell Carcinoma (Grawitz Tumor)
12/2022 - 04/2022
2Carcinoma (Carcinomatosis)
11/2022 - 10/2020
2COVID-19
01/2022 - 09/2021
2Adenocarcinoma
08/2021 - 12/2020
2Brain Neoplasms (Brain Tumor)
10/2020 - 08/2017
1Sickle Cell Anemia (Hemoglobin S Disease)
12/2023
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2023
1Osteoarthritis
07/2023
1Brain Diseases (Brain Disorder)
07/2023
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
07/2023
1Rheumatoid Arthritis
07/2023
1Autoimmune Diseases (Autoimmune Disease)
01/2023
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
04/2022
1Triple Negative Breast Neoplasms
02/2022

Drug/Important Bio-Agent (IBA)

32Monoclonal AntibodiesIBA
02/2024 - 04/2019
25Immunoglobulin G (IgG)IBA
02/2024 - 04/2019
13human ERBB2 proteinIBA
02/2024 - 08/2019
13Proteins (Proteins, Gene)FDA Link
11/2023 - 06/2007
11TeaIBA
01/2023 - 03/2002
10Trastuzumab (Herceptin)FDA Link
02/2024 - 08/2019
8Complement System Proteins (Complement)IBA
10/2023 - 04/2020
7PolyphenolsIBA
07/2023 - 01/2021
7ErbB Receptors (EGF Receptor)IBA
06/2022 - 08/2020
5podocalyxinIBA
12/2023 - 08/2017
5Glycoproteins (Glycoprotein)IBA
02/2023 - 09/2018
4Epithelial Cell Adhesion MoleculeIBA
01/2023 - 12/2020
4CoffeeFDA Link
01/2023 - 10/2020
4epigallocatechin gallate (epigallocatechin-3-gallate)IBA
01/2022 - 03/2002
4TankyrasesIBA
11/2018 - 01/2005
3AntibodiesIBA
02/2024 - 08/2020
3Immunoconjugates (Immunoconjugate)IBA
02/2024 - 04/2020
3AntigensIBA
02/2024 - 10/2020
3EnzymesIBA
01/2023 - 01/2016
3Telomerase (Telomerase Reverse Transcriptase)IBA
06/2007 - 01/2005
2Reactive Oxygen Species (Oxygen Radicals)IBA
11/2023 - 01/2016
2Matrix Metalloproteinases (MMPs)IBA
07/2023 - 01/2023
2ZincIBA
07/2023 - 01/2023
2Metalloproteases (Metalloproteinases)IBA
07/2023 - 01/2023
2pyrimidineIBA
01/2023 - 11/2021
2MicroRNAs (MicroRNA)IBA
01/2023 - 06/2022
2Dihydroorotate DehydrogenaseIBA
01/2023 - 11/2021
2intervenolinIBA
12/2021 - 04/2018
2Chlorogenic AcidIBA
01/2021 - 10/2020
2Protein Isoforms (Isoforms)IBA
11/2020 - 01/2020
2DNA (Deoxyribonucleic Acid)IBA
11/2018 - 06/2007
1DisulfidesIBA
02/2024
1Cell Surface ReceptorsIBA
02/2024
1Chimeric Antigen ReceptorsIBA
02/2024
1GlobinsIBA
12/2023
1Conditioned Culture MediaIBA
11/2023
1Antineoplastic Agents (Antineoplastics)IBA
11/2023
1oligomycin AIBA
11/2023
1A-factor (Streptomyces)IBA
11/2023
1oligomycin sensitivity-conferring protein (complex V)IBA
11/2023
1Coloring Agents (Dyes)IBA
11/2023
1pertuzumabIBA
09/2023
1Tyrosine Kinase InhibitorsIBA
06/2023
1Insulin Receptor Substrate ProteinsIBA
06/2023
1Oncostatin MIBA
06/2023
1vandetanib (ZD6474)IBA
06/2023
1Tyrosine (L-Tyrosine)FDA Link
06/2023
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
06/2023
1Phosphotransferases (Kinase)IBA
06/2023
1Extracellular Matrix ProteinsIBA
01/2023
1FlavonoidsIBA
12/2022
1Biomarkers (Surrogate Marker)IBA
12/2022
1IsoflavonesIBA
12/2022
1Epidermal Growth Factor (EGF)IBA
11/2022
1Surface Antigens (Surface Antigen)IBA
02/2022
1Angiotensin Receptors (Angiotensin II Receptor)IBA
01/2022
1Angiotensin-Converting Enzyme 2IBA
01/2022
1SARS-CoV-2 spike proteinIBA
01/2022
1PhytochemicalsIBA
01/2022
1Lactic Acid (Lactate)FDA LinkGeneric
12/2021
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
12/2021
1CurcuminIBA
01/2021
1ResveratrolIBA
01/2021

Therapy/Procedure

23Therapeutics
02/2024 - 01/2005
2Immunotherapy
02/2024 - 09/2022